The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of single/dual HER2 inhibition and chemotherapy (CT) backbone upon pathologic complete response (pCR) in patients receiving neoadjuvant CT for operable/locally advanced breast cancer (O/LABC): A treatment-interaction analysis of randomized trials.
Jenny Furlanetto
No relevant relationships to disclose
Vanja Vaccaro
No relevant relationships to disclose
Chiara Caliolo
No relevant relationships to disclose
Michele De Laurentiis
No relevant relationships to disclose
Maria Bonomi
No relevant relationships to disclose
Sara Pilotto
No relevant relationships to disclose
Francesco Massari
No relevant relationships to disclose
Rolando Nortilli
No relevant relationships to disclose
Daniela Cianniello
No relevant relationships to disclose
Francesco Cognetti
No relevant relationships to disclose
Diana Giannarelli
No relevant relationships to disclose
Giampaolo Tortora
No relevant relationships to disclose
Emilio Bria
No relevant relationships to disclose